SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $392,945,000 | +165.6% | 2,273,856 | +76.7% | 0.13% | +168.1% |
| Q4 2014 | $147,920,000 | -37.4% | 1,286,930 | -14.9% | 0.05% | -37.3% |
| Q3 2014 | $236,269,000 | +242.4% | 1,512,217 | +170.3% | 0.08% | +240.9% |
| Q2 2014 | $68,999,000 | +130.1% | 559,372 | +93.3% | 0.02% | +120.0% |
| Q1 2014 | $29,982,000 | +196.1% | 289,375 | +157.1% | 0.01% | +233.3% |
| Q4 2013 | $10,125,000 | +5.6% | 112,574 | -21.5% | 0.00% | -25.0% |
| Q3 2013 | $9,591,000 | +31.4% | 143,413 | +30.0% | 0.00% | +33.3% |
| Q2 2013 | $7,299,000 | -62.9% | 110,338 | -77.3% | 0.00% | -62.5% |
| Q4 2012 | $19,688,000 | +9.9% | 486,458 | +14.9% | 0.01% | +14.3% |
| Q3 2012 | $17,920,000 | -16.8% | 423,247 | +7.0% | 0.01% | -30.0% |
| Q2 2012 | $21,541,000 | +185.5% | 395,677 | +175.3% | 0.01% | +150.0% |
| Q1 2012 | $7,545,000 | – | 143,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|